Global Value Messaging and P&MA Strategy for a CAR T Cell Therapy

Home / Intelligence / Case Studies / Global Value Messaging and P&MA Strategy for a CAR T Cell Therapy

Trinity completed an engagement to support the successful launch of a CAR T cell therapy with distinct clinical profile in a competitive landscape.

Geographic Scope: Netherlands Flag Belgian Flag Swedish Flag Danish Flag Swiss Flag

Client Situation

The client asked Trinity to develop and externally validate global payer value messages and the associated evidence set for their CAR T cell therapy. They also required support with developing a robust global pricing and market access strategy for their asset.

Trinity’s Solution

Trinity conducted focus groups and In-Depth-Interviews (IDIs) with key payer and provider stakeholders in scope markets to understand the evolving cell therapy landscape and identify unique opportunities and challenges that are relevant for “one-time” therapies.


  • Outputs from internal workshops summarizing alignment among cross-functional stakeholders
  • Refined value story and supporting exhibits for the CAR T cell therapy
  • Key learnings and actionable recommendations informing pricing and market access strategy

Project Outcomes & Impact

The client was provided with an impactful value, access, and pricing strategy for a CAR T cell therapy product to successfully convey differentiation in an increasingly crowded and competitive environment.

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email